Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Apter

Showing results (31-40 of 86) with videos related to

Pageof 9
Sort By:
Obstetrics and Gynecology|November 19, 2013
Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trialAnita Nelson, Dan Apter, Brian Hauck, et al.
International Journal of Cancer|April 12, 2012
Occurrence of vaccine and non-vaccine human papillomavirus types in adolescent Finnish females 4 years post-vaccinationJohanna Palmroth, Marko Merikukka, Jorma Paavonen, et al.
Fertility and Sterility|March 27, 2016
A 12-month multicenter, randomized study comparing the levonorgestrel intrauterine system with the etonogestrel subdermal implantDan Apter, Paula Briggs, Marjo Tuppurainen, et al.
BMJ Open|June 1, 2022
Association of <i>Chlamydia trachomatis</i> infection with cervical atypia in adolescent women with short-term or long-term use of oral contraceptives: a longitudinal study in HPV vaccinated womenIndira Adhikari, Tiina Eriksson, Katja Harjula, et al.
Lakartidningen|November 25, 2003
[Preventive vaccines against papillomavirus and cervix cancer will soon enter clinical practice]Matti Lehtinen, Christian Malm, Dan Apter, et al.
Contraception|February 14, 2016
A Phase III, single-arm study of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5mg) in postmenarcheal adolescentsKristina Gemzell-Danielsson, Kai J Buhling, Sylvia M Dermout, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|December 26, 2018
Corrigendum to "Evaluation of a new, low-dose levonorgestrel intrauterine contraceptive system over 5 years of use" [Eur J Obstetr Gynecol Reprod Biol 210 (2017) 22-28]Kristina Gemzell-Danielsson, Dan Apter, Sylvia Dermout, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|August 2, 2005
Contraceptive efficacy, compliance and beyond: factors related to satisfaction with once-weekly transdermal compared with oral contraceptionWolfgang Urdl, Dan Apter, Alan Alperstein, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|December 9, 2016
Evaluation of a new, low-dose levonorgestrel intrauterine contraceptive system over 5 years of useKristina Gemzell-Danielsson, Dan Apter, Sylvia Dermout, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|December 17, 2010
Impact of HPV vaccination on young women's quality of life - a five year follow-up studySarah Woodhall, Tiina Eriksson, Anna-Mari Nykänen, et al.
Pageof 9

Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
Obstetrics and Gynecology|November 19, 2013
Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trialAnita Nelson, Dan Apter, Brian Hauck, et al.
International Journal of Cancer|April 12, 2012
Occurrence of vaccine and non-vaccine human papillomavirus types in adolescent Finnish females 4 years post-vaccinationJohanna Palmroth, Marko Merikukka, Jorma Paavonen, et al.
Fertility and Sterility|March 27, 2016
A 12-month multicenter, randomized study comparing the levonorgestrel intrauterine system with the etonogestrel subdermal implantDan Apter, Paula Briggs, Marjo Tuppurainen, et al.
BMJ Open|June 1, 2022
Association of <i>Chlamydia trachomatis</i> infection with cervical atypia in adolescent women with short-term or long-term use of oral contraceptives: a longitudinal study in HPV vaccinated womenIndira Adhikari, Tiina Eriksson, Katja Harjula, et al.
Lakartidningen|November 25, 2003
[Preventive vaccines against papillomavirus and cervix cancer will soon enter clinical practice]Matti Lehtinen, Christian Malm, Dan Apter, et al.
Contraception|February 14, 2016
A Phase III, single-arm study of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5mg) in postmenarcheal adolescentsKristina Gemzell-Danielsson, Kai J Buhling, Sylvia M Dermout, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|December 26, 2018
Corrigendum to "Evaluation of a new, low-dose levonorgestrel intrauterine contraceptive system over 5 years of use" [Eur J Obstetr Gynecol Reprod Biol 210 (2017) 22-28]Kristina Gemzell-Danielsson, Dan Apter, Sylvia Dermout, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|August 2, 2005
Contraceptive efficacy, compliance and beyond: factors related to satisfaction with once-weekly transdermal compared with oral contraceptionWolfgang Urdl, Dan Apter, Alan Alperstein, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|December 9, 2016
Evaluation of a new, low-dose levonorgestrel intrauterine contraceptive system over 5 years of useKristina Gemzell-Danielsson, Dan Apter, Sylvia Dermout, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|December 17, 2010
Impact of HPV vaccination on young women's quality of life - a five year follow-up studySarah Woodhall, Tiina Eriksson, Anna-Mari Nykänen, et al.
Pageof 9